Kumagai Reiko, Kitajima Tsuyoshi, Hirose Marina, Iwata Nakao
Department of Psychiatry, Fujita Health University, School of Medicine, Toyoake, Aichi, Japan.
Fujita Med J. 2020;6(2):54-58. doi: 10.20407/fmj.2019-011. Epub 2020 Feb 11.
Idiopathic rapid eye movement (REM) sleep behavior disorder (iRBD) is characterized by abnormal and potentially violent behaviors during REM sleep, typically observed in older adult subjects. Previous reports have described a high risk for neurodegeneration in patients with iRBD; however, to date, no published study has analyzed an adequate number of Japanese patients. We retrospectively analyzed the incidence of neurodegenerative disorders among patients diagnosed with iRBD in our department.
The data were retrospectively collected from patients' medical records. The patients included in the study were diagnosed with iRBD using polysomnography in our department, from May 1, 2005 to November 30, 2018, with a follow-up of ≥6 months. Using the Kaplan-Meier (KM) method, we estimated the incidence of later diagnoses of neurodegenerative disorders among this cohort of patients with iRBD.
Among 57 consecutive patients diagnosed with iRBD, 14 (24.6%) were later diagnosed with neurodegenerative disorders. Using the KM method, we estimated that the incidence was as high as 18.5% and 68.1% at 5 and 10 years, respectively. Of the 14 patients who developed neurodegenerative disorders, 12 (85.7%) had α-synucleinopathies (Parkinson's disease in eight patients, Lewy body dementia in three, Alzheimer's-type dementia in two, and multiple system atrophy in one).
The results of this study suggest the high likelihood that iRBD may subsequently progress to neurodegenerative disorders in Japanese patients, a finding similar to those previously reported by studies performed overseas. Further studies using standardized prospective evaluation methods must be performed in Japan.
特发性快速眼动(REM)睡眠行为障碍(iRBD)的特征是在REM睡眠期间出现异常且可能具有暴力性的行为,这在老年受试者中较为常见。先前的报告描述了iRBD患者发生神经退行性变的高风险;然而,迄今为止,尚无已发表的研究对足够数量的日本患者进行分析。我们回顾性分析了在我科被诊断为iRBD的患者中神经退行性疾病的发生率。
数据从患者病历中回顾性收集。纳入研究的患者于2005年5月1日至2018年11月30日在我科通过多导睡眠图诊断为iRBD,并进行了≥6个月的随访。我们使用Kaplan-Meier(KM)方法估计了这组iRBD患者中神经退行性疾病后续诊断的发生率。
在连续57例被诊断为iRBD的患者中,有14例(24.6%)后来被诊断为神经退行性疾病。使用KM方法,我们估计5年和10年时的发生率分别高达18.5%和68.1%。在发生神经退行性疾病的14例患者中,12例(85.7%)患有α-突触核蛋白病(8例为帕金森病,3例为路易体痴呆,2例为阿尔茨海默病型痴呆,1例为多系统萎缩)。
本研究结果表明,iRBD在日本患者中随后进展为神经退行性疾病的可能性很高,这一发现与先前在海外进行的研究所报告的结果相似。在日本必须使用标准化的前瞻性评估方法进行进一步研究。